BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-54@pharmaconomics
DTSTAMP:20260707T021626Z
DTSTART;VALUE=DATE:20261201
DTEND;VALUE=DATE:20261202
SUMMARY:CTRP Phase 3 — CTX-009
DESCRIPTION:Phase 3 trial results for CTX-009 in Biliary Tract Cancer are due Dec 1\, 2026. A clean hit validates the program\; a miss can gap the stock down hard.\n\nPrimary source: https://clinicaltrials.gov/study/NCT05506943\n\nTrack it: https://pharmaconomics.com/e/54
URL:https://pharmaconomics.com/e/54
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:CTRP catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR